Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement
Mol Ther Oncol, 33 (2), 200954
DOI 10.1016/j.omton.2025.200954, PubMed 40520577
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial
Lancet Oncol, 26 (6), 695-706
DOI 10.1016/S1470-2045(25)00197-4, PubMed 40339593
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial
J Clin Oncol, 43 (17), 1972-1983
DOI 10.1200/JCO-24-01386, PubMed 40249893